Skip to main content
OpenTrials

Clinical trial condition

Hemorrhagic Disorders

Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.

4,576 public trials 831 recruiting studies
Refine in advanced search Browse all conditions

Hemorrhagic Disorders trial results

Active, Not Recruiting

Study of Plinabulin and Pegfilgrastim in People With Multiple Myeloma Undergoing an Autologous Hematopoietic Stem Cell Transplant (AHCT)

NCT05130827

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

A Phase 1/2 Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Glanzmann Thrombasthenia

NCT06211634

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Blood Platelet Disorders, +7 more
Locations
  • University of California, San Diego (UCSD) (Part B/C) La Jolla, California, United States
  • Tulane University Medical Center (Part B/C) New Orleans, Louisiana, United States
  • Mayo Clinic - Rochester (Part B/C) Rochester, Minnesota, United States
  • Hemophilia Center of Western Pennsylvania (HCWP) (Part B/C) Pittsburgh, Pennsylvania, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused Etentamig (ABBV-383) in Combination With Anti-Cancer Regimens for the Treatment of Adult Participants With Relapsed/Refractory Multiple Myeloma

NCT05259839

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • University of Arkansas for Medical Sciences /ID# 243096 Little Rock, Arkansas, United States
  • Sylvester Comprehensive Cancer Center /ID# 243673 Miami, Florida, United States
  • Moffitt Cancer Center /ID# 243437 Tampa, Florida, United States
  • University of Maryland, Baltimore /ID# 243679 Baltimore, Maryland, United States
View all 49 locations
View Trial Details
Active, Not Recruiting

A Study of Romosozumab in Women With Multiple Myeloma and Osteoporosis

NCT05775094

Conditions
Blood Protein Disorders, Bone Diseases, Bone Diseases, Metabolic, +18 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

Study of Lenalidomide/Ixazomib/Dexamethasone/Daratumumab in Transplant-Ineligible Patients With Newly Diagnosed MM

NCT04009109

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Northern Light Eastern Maine Medical Center Bangor, Maine, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
View Trial Details
Active, Not Recruiting

Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IX

NCT03754790

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Phoenix Childrens Hospital Site Number : 8400009 Phoenix, Arizona, United States
  • Children's Hospital Los Angeles Site Number : 8400019 Los Angeles, California, United States
  • Center for Inherited Blood Disorders (CIBD) Site Number : 8400016 Orange, California, United States
  • Nemours Children's Clinic Site Number : 8400008 Jacksonville, Florida, United States
View all 79 locations
View Trial Details
Active, Not Recruiting

Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma

NCT04270409

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • UCLA Site Number : 8400010 Los Angeles, California, United States
  • Colorado Blood Cancer Institute Site Number : 8400007 Denver, Colorado, United States
  • Cancer Specialist of North Florida Site Number : 8400011 Jacksonville, Florida, United States
  • University of Miami Site Number : 8400012 Miami, Florida, United States
View all 105 locations
View Trial Details

Related conditions